Scheme 4: a) Oxidation of the SO-labile linker of a prodrug and b) Facile synthesis, cleavage of aminoacrylate, and release of a parent drug after its oxidative cleavage. Aadapted from the [49] and reproduced with permission from the Royal Society of Chemistry (RSC). Copyright 2012.